UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry

Archives of gynecology and obstetrics, 2024-06, Vol.309 (6), p.2811-2819

2024

Volltextzugriff (PDF)

The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse

Breast cancer research and treatment, 2013-04, Vol.138 (2), p.509-517

2013

Volltextzugriff (PDF)

Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse

Annals of oncology, 2015-06, Vol.26 (6), p.1155-1160

2015

Volltextzugriff (PDF)

High intensity focused ultrasound (HIFU) for the treatment of symptomatic breast fibroadenoma

International journal of hyperthermia, 2018-12, Vol.35 (1), p.463-470

2018

Volltextzugriff (PDF)

Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease

Gynecologic oncology, 2019-04, Vol.153 (1), p.49-54

2019

Volltextzugriff (PDF)

Reply to the letter to the editor ‘Journey to a faraway land’ by Alkan et al

Annals of oncology, 2015-10, Vol.26 (10), p.2200-2201

2015

Volltextzugriff (PDF)

Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase

Gynecologic oncology, 2013-08, Vol.130 (2), p.362-368

2013

Volltextzugriff (PDF)

Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)

ESMO open, 2024-05, Vol.9 (5), p.103009, Article 103009

2024

Volltextzugriff (PDF)

Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

Journal of cancer research and clinical oncology, 2016-08, Vol.142 (8), p.1847-1853

2016

Volltextzugriff (PDF)

Circulating Tumor Cells in Early-Stage Breast Cancer

Geburtshilfe und Frauenheilkunde, 2011-12, Vol.71 (12), p.1067-1072

2011

Volltextzugriff (PDF)

Oncolytic Viruses to Treat Ovarian Cancer Patients – a Review of Results From Clinical Trials

Geburtshilfe und Frauenheilkunde, 2012-02, Vol.72 (2), p.132-136

2012

Volltextzugriff (PDF)

Trastuzumab Administration in Patients with Metastatic Breast Cancer – Experience of a Large University Breast Center

Geburtshilfe und Frauenheilkunde, 2014-06, Vol.74 (6), p.563-568

2014

Volltextzugriff (PDF)

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The journal of pathology. Clinical research, 2023-05, Vol.9 (3), p.208-222

2023

Volltextzugriff (PDF)

Abstract P1-01-16: Detection of disseminated tumor cells in DCIS patients impacts local recurrence

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-01-16

2018

Volltextzugriff (PDF)

P142 Results of the 3rd interim analysis of C-Patrol: a non-interventional study on olaparib in german routine clinical practice

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A144-A144

2019

Volltextzugriff (PDF)

Abstract OT1-11-02: PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/ metastatic setting (NCT02338167)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-11-02-OT1-11-02

2019

Volltextzugriff (PDF)

Abstract P6-17-37: Therapy landscape of patients with metastatic, HER2 positive breast cancer - Data from the real world breast cancer registry PRAEGNANT (NCT02338167)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-17-37

2019

Volltextzugriff (PDF)

Abstract P6-17-22: Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-17-22

2019

Volltextzugriff (PDF)

Abstract P3-11-05: Reliability and acceptance of e-based survey instruments for measuring patient reported outcomes (PRO) in breast cancer patients: First results of the ePROCOM study

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P3-P3-11-05

2017

Volltextzugriff (PDF)

Abstract P3-01-14: A nomogram to predict the likelihood of axillary non-sentinel lymph node metastases in sentinel lymph node positive primary breast cancer patients

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-01-14

2016

Volltextzugriff (PDF)

Abstract P2-08-18: Gene and protein expression profiles of HER2, ER, PR, and Ki67 in matched pair samples of primary (PBC) and metastatic breast cancer (MBC) tissues

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-08-18

2016

Volltextzugriff (PDF)

Abstract P2-02-06: Impact of apoptotic circulating tumor cells in metastatic breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-02-06

2016

Volltextzugriff (PDF)

Abstract P6-11-10: Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-11-10

2018

Volltextzugriff (PDF)

Abstract P1-07-20: Developing prognostic indicators of poor outcomes in PRAEGNANT metastatic breast cancer cohort

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-07-20

2018

Volltextzugriff (PDF)

1 – 25 von 459

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(386)
Mit Volltextzugriff
(380)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(344)
Deutsch
(121)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry

The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse

Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse

High intensity focused ultrasound (HIFU) for the treatment of symptomatic breast fibroadenoma

Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease

Reply to the letter to the editor ‘Journey to a faraway land’ by Alkan et al

Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase

Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)

Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Circulating Tumor Cells in Early-Stage Breast Cancer

Oncolytic Viruses to Treat Ovarian Cancer Patients – a Review of Results From Clinical Trials

Trastuzumab Administration in Patients with Metastatic Breast Cancer – Experience of a Large University Breast Center

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

Abstract P1-01-16: Detection of disseminated tumor cells in DCIS patients impacts local recurrence

P142 Results of the 3rd interim analysis of C-Patrol: a non-interventional study on olaparib in german routine clinical practice

Abstract OT1-11-02: PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/ metastatic setting (NCT02338167)

Abstract P6-17-37: Therapy landscape of patients with metastatic, HER2 positive breast cancer - Data from the real world breast cancer registry PRAEGNANT (NCT02338167)

Abstract P6-17-22: Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167)

Abstract P3-11-05: Reliability and acceptance of e-based survey instruments for measuring patient reported outcomes (PRO) in breast cancer patients: First results of the ePROCOM study

Abstract P3-01-14: A nomogram to predict the likelihood of axillary non-sentinel lymph node metastases in sentinel lymph node positive primary breast cancer patients

Abstract P2-08-18: Gene and protein expression profiles of HER2, ER, PR, and Ki67 in matched pair samples of primary (PBC) and metastatic breast cancer (MBC) tissues

Abstract P2-02-06: Impact of apoptotic circulating tumor cells in metastatic breast cancer

Abstract P6-11-10: Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

Abstract P1-07-20: Developing prognostic indicators of poor outcomes in PRAEGNANT metastatic breast cancer cohort

Suchergebnisse filtern